1. Home
  2. LVRO vs AKBA Comparison

LVRO vs AKBA Comparison

Compare LVRO & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LVRO
  • AKBA
  • Stock Information
  • Founded
  • LVRO 2017
  • AKBA 2007
  • Country
  • LVRO Brazil
  • AKBA United States
  • Employees
  • LVRO N/A
  • AKBA N/A
  • Industry
  • LVRO Blank Checks
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LVRO Finance
  • AKBA Health Care
  • Exchange
  • LVRO Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • LVRO 387.1M
  • AKBA 336.2M
  • IPO Year
  • LVRO N/A
  • AKBA 2014
  • Fundamental
  • Price
  • LVRO $3.25
  • AKBA $2.37
  • Analyst Decision
  • LVRO Strong Buy
  • AKBA Strong Buy
  • Analyst Count
  • LVRO 3
  • AKBA 1
  • Target Price
  • LVRO $6.83
  • AKBA $7.50
  • AVG Volume (30 Days)
  • LVRO 14.3K
  • AKBA 2.4M
  • Earning Date
  • LVRO 03-06-2025
  • AKBA 03-13-2025
  • Dividend Yield
  • LVRO N/A
  • AKBA N/A
  • EPS Growth
  • LVRO N/A
  • AKBA N/A
  • EPS
  • LVRO N/A
  • AKBA N/A
  • Revenue
  • LVRO $1,691,812,087.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • LVRO N/A
  • AKBA N/A
  • Revenue Next Year
  • LVRO $12.53
  • AKBA $30.85
  • P/E Ratio
  • LVRO N/A
  • AKBA N/A
  • Revenue Growth
  • LVRO 0.48
  • AKBA N/A
  • 52 Week Low
  • LVRO $3.06
  • AKBA $0.80
  • 52 Week High
  • LVRO $8.33
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • LVRO 27.62
  • AKBA 75.15
  • Support Level
  • LVRO $3.06
  • AKBA $1.72
  • Resistance Level
  • LVRO $3.97
  • AKBA $2.00
  • Average True Range (ATR)
  • LVRO 0.44
  • AKBA 0.11
  • MACD
  • LVRO -0.16
  • AKBA 0.04
  • Stochastic Oscillator
  • LVRO 7.48
  • AKBA 100.00

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: